HPM and Riparian to Co-Host Webinar on CMS Misclassification Penalties Rule
FDA Law Blog
DECEMBER 9, 2024
On Wednesday, December 11, Hyman, Phelps & McNamara, P.C. (HPM) and Riparian LLC will co-host a webinar on an important CMS rule imposing penalties for misclassification of drugs and other reporting errors under the Medicaid Drug Rebate Program. (See our post on this rule here.) The Webinar will explore the CMS rule and provide actionable recommendations for manufacturers on how to navigate the new requirements.
Let's personalize your content